Ye Hua
Conseiller Juridique Général chez Hutchison MediPharma Ltd.
Postes actifs de Ye Hua
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Conseiller Juridique Général | - | - |
Historique de carrière de Ye Hua
Anciens postes connus de Ye Hua
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CELGENE | Directeur Technique/Scientifique/R&D | 01/07/2011 | 01/03/2014 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Directeur Technique/Scientifique/R&D | - | - |
| HUTCHMED (CHINA) LIMITED | Conseiller Juridique Général | - | - |
| The Shanghai Cancer Institute | Corporate Officer/Principal | - | - |
Formation de Ye Hua
| Shanghai Medical College of Fudan University | Undergraduate Degree |
| McGill University | Undergraduate Degree |
Statistiques
Internationale
| Chine | 4 |
| Etats-Unis | 3 |
| Hong Kong | 2 |
Opérationnelle
| General Counsel | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 2 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HUTCHMED (CHINA) LIMITED | Health Technology |
| Entreprise privées | 4 |
|---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
| The Shanghai Cancer Institute | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
